Česká centra, Czech Centres

Česká centra / Czech centres - logo


9 sep. 2020 19:00

Global Science Café 3 - Cell & Gene Therapy: The future has already begun 9/9 19:00

Dr. Šimíček´s research is the development of cell therapy for the treatment of tumours of the hematopoietic system.

GuestDr. Michal Šimíček, Ph. D.

Presenter: Dr. Michael Londesborough, Ph.D.

Online: Czech Centres FB

Language: English


Cells like trained tumour killers 

One of the main areas of Dr. Šimíček´s research is the development of cell therapy for the treatment of tumours of the hematopoietic system. Cell therapy is a completely new and extremely effective approach in the fight against cancer. Patients are given live cells of the immune system equipped with receptors that help to recognize and eliminate the tumour in a targeted way. This method of treatment is very safe because it can regulate the activity of cells and possibly remove them from the body. The problem of the treatment is the price, the goal of Michal Šimíček's team is the cost of treatment, which is high because completely new cells must be prepared for each patient, as similar as possible to their own cells. And it is M. Šimíček who wants to create universal cells that could be taken from any donor, and it would be enough to get cells from the blood and significantly reduce the price. 


About the guest

RNDr. Michal Šimíček, Ph.D. was awarded the Neuron prize in the field of medicine in 2019. He became a member of the elite group of Czech scientists alongside for example the plastic surgeon Bohdan Pomahač. He achieved his success in biomedical research by examining the processes causing the malignant diseases and their drug resistance.  He got his education and then participated for a long time in the workplaces in Leuven (Belgium), London and Cambridge but then he decided to go back to Moravia where he launched a first-rate scientific centre in the Department of Haematooncology at the University Hospital in Ostrava. At the centre, he and his team develop unique technologies of cell therapy against various types of cancer. In collaboration with the biomedical centre of Primecell Bioscience, he would launch the production of his own cell therapy preparations, and University Hospital Ostrava would act as an important international centre for the treatment of oncological diseases such as leukaemia or multiple myeloma.

Michal Šimíček, winner of the Neuron Award for promising young scientists in 2019 in the field of medicine © Neuron Endowment Fund 


About the presenter

Dr. Michael Londesborough, Ph.D. is a British scientist working at the Institute of Inorganic Chemistry of the Academy of Sciences of the Czech Republic, where he focuses on research into boron compounds. He has won three prizes for Czech / Slovak young inorganic chemists, collaborates on projects with the British Council in Prague and on popularization projects for the Academy of Sciences of the Czech Republic, Czech Television and the National Technical Museum. He focuses on making science accessible to the general public, teaching young people, and strengthening international relations between young scientists (FameLab competition). In 2009 the Academy of Sciences of the Czech Republic awarded him the Vojtěch Náprstek Medal for popularizing science.

Michael Londesborough © Michael Londesborough 




9 sep. 2020 19:00

Georganiseerd door:

České centrum

Geen herinnering mogelijk